<p>INNOVENT BIO announced that its operating revenue in the first half of 2025 was 5.953 billion yuan, a year-on-year increase of 50.6%; the profit during the period was 834 million yuan, compared to a loss of 393 million yuan in the same period last year. Non-IFRS profit was 1.213 billion yuan, compared to a loss of 160 million yuan in the same period last year</p>

01801

<p>INNOVENT BIO achieved operating revenue of 5.953 billion yuan in the first half of 2025, a year-on-year increase of 50.6%. The company's profit during this period was 834 million yuan, while it recorded a loss of 393 million yuan in the same period last year. According to Non-IFRS standards, the profit was 1.213 billion yuan, compared to a loss of 160 million yuan in the same period last year</p>

INNOVENT BIO: Revenue in the first half of the year was 5.953 billion yuan, a year-on-year increase of 50.6%